 12. Subjects must be candidate for intralesional injection into cutaneous, subcutaneous or nodal tumors with or without image ultrasound guidance defined as one or more of the following At least 1 injectable lesion 5 mm in longest diameter, multiple injectable lesions that in aggregate have a longest diameter of 5 mm. 